• English
    • Deutsch
  • English 
    • English
    • Deutsch
  • Login
View Item 
  •   Home
  • Universität Ulm / Medizin
  • Publikationen
  • View Item
  •   Home
  • Universität Ulm / Medizin
  • Publikationen
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Lipoatrophy Is Associated with an Increased Risk of Hashimoto's Thyroiditis and Coeliac Disease in Female Patients with Type 1 Diabetes

Thumbnail
HRP351708.pdf (463.0Kb)

peer-reviewed

Erstveröffentlichung
2013-06-18
Authors
Salgin, Burak
Meissner, Thomas
Beyer, Peter
Haberland, Holger
Borkenstein, Martin
et al.
Wissenschaftlicher Artikel


Published in
Hormone Research in Paediatrics ; 79 (2013), 6. - S. 368-372. - ISSN 1663-2818. - eISSN 1663-2826
Link to original publication
https://dx.doi.org/10.1159/000351708
Faculties
Medizinische Fakultät
Institutions
Institut für Epidemiologie und Medizinische Biometrie
External cooperations
Universitätsklinikum Düsseldorf
Evangelischen Krankenhaus Oberhausen
Sana Klinikum
RKH Kliniken
Universitätsklinikum Essen
et al.
Document version
published version (publisher's PDF)
Abstract
Background/Aims: Lipoatrophy (LA) is a rare, possibly under-recognised side effect of insulin treatment of unclear aetiology. The aim of this study was to describe the characteristics of patients with type 1 diabetes (T1D) who have LA and to explore the relationship between LA and other autoimmune diseases based on the hypothesis that additional autoimmune phenomena are more prevalent in T1D patients with LA. Methods: This was a cross-sectional observational study of T1D patients with LA in comparison to T1D patients without LA who are registered with the Diabetes Patienten-Verlaufsdokumentationssystem database of 241,650 patients in Germany and Austria. Results: Hashimoto's thyroiditis and coeliac disease were more prevalent in patients with LA (p < 0.001 for both). LA was associated with an increased risk of Hashimoto's thyroiditis and coeliac disease in female patients [odds ratio (OR) 2.5, p = 0.003, and OR 3.1, p = 0.02, respectively]. This relationship persisted after adjustment for current age, duration of diabetes and calendar year of treatment (OR 2.7, p = 0.002, and OR 3.5, p = 0.01, respectively). Conclusion: These findings support the hypothesis that an immune complex-mediated inflammatory process may be important in the development of LA. © In Copyright http://rightsstatements.org/vocab/InC/1.0/
Subject headings
[GND]: Diabetes mellitus Typ 1 | Berardinelli-Syndrom | Hashimoto-Thyreoiditis
[MeSH]: Diabetes mellitus, Type 1 | Drug-related side effects and adverse reactions | Hashimoto disease | Celiac disease
[Free subject headings]: Type 1 diabetes | Lipoatrophy | Hashimoto’s thyroiditis | Coeliac disease | Diabetes Patienten-Verlaufsdokumentationssystem
[DDC subject group]: DDC 610 / Medicine & health
Rights notice
Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
 
This publication is with permission of the rights owner freely accessible due to an Alliance licence and a national licence (funded by the DFG, German Research Foundation) respectively.
License
In Copyright
http://rightsstatements.org/vocab/InC/1.0/

Metadata
Show full item record

DOI & citation

Please use this identifier to cite or link to this item: http://dx.doi.org/10.18725/OPARU-40125

Salgin, Burak et al. (2021): Lipoatrophy Is Associated with an Increased Risk of Hashimoto's Thyroiditis and Coeliac Disease in Female Patients with Type 1 Diabetes. Open Access Repositorium der Universität Ulm und Technischen Hochschule Ulm. http://dx.doi.org/10.18725/OPARU-40125
Citation formatter >



Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement
 

 

Advanced Search

Browse

All of OPARUCommunities & CollectionsPersonsInstitutionsPublication typesUlm SerialsDewey Decimal ClassesEU projects UlmDFG projects UlmOther projects Ulm

My Account

LoginRegister

Statistics

View Usage Statistics

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement